rdf:type |
|
lifeskim:mentions |
umls-concept:C0038952,
umls-concept:C0087111,
umls-concept:C0206015,
umls-concept:C0243127,
umls-concept:C0262950,
umls-concept:C0392747,
umls-concept:C0439849,
umls-concept:C0443331,
umls-concept:C0445223,
umls-concept:C0458083,
umls-concept:C0936223,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1954261
|
pubmed:issue |
11
|
pubmed:dateCreated |
2007-6-4
|
pubmed:abstractText |
Elevated serum levels of biochemical markers of bone turnover and YKL-40 in patients with metastatic prostate cancer (PC) at the time of diagnosis are associated to poor prognosis. In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adipokines,
http://linkedlifedata.com/resource/pubmed/chemical/CHI3L1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Procollagen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/procollagen Type I N-terminal...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3244-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17545529-Adipokines,
pubmed-meshheading:17545529-Aged,
pubmed-meshheading:17545529-Aged, 80 and over,
pubmed-meshheading:17545529-Bone and Bones,
pubmed-meshheading:17545529-Glycoproteins,
pubmed-meshheading:17545529-Hormones,
pubmed-meshheading:17545529-Humans,
pubmed-meshheading:17545529-Lectins,
pubmed-meshheading:17545529-Male,
pubmed-meshheading:17545529-Middle Aged,
pubmed-meshheading:17545529-Neoplasm Metastasis,
pubmed-meshheading:17545529-Neoplasm Transplantation,
pubmed-meshheading:17545529-Peptide Fragments,
pubmed-meshheading:17545529-Procollagen,
pubmed-meshheading:17545529-Prostatic Neoplasms,
pubmed-meshheading:17545529-Retrospective Studies,
pubmed-meshheading:17545529-Treatment Outcome,
pubmed-meshheading:17545529-Tumor Markers, Biological
|
pubmed:year |
2007
|
pubmed:articleTitle |
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival.
|
pubmed:affiliation |
Department of Rheumatology, Herlev Hospital, , Denmark. julia.johansen@post3.tele.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|